EUVIMEDEUVIMED entdecken
Crossref

Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia‐Reperfusion Injury

Şahhan Kılıç iD, Süha Asal iD, Mert Babaoğlu iD, Cumaali Demirtaş iD, Samet Yavuz iD, Eray Metin Güler iD, Hakan Beyaztaş iD, Yavuz Aslan iD, Cansu Türker Sarıçoban iD, Özge Bengisu Uysal iD, Mehmet Yıldırım iD, Mert İlker Hayıroğlu iD und 1 weitere

Fundamental & Clinical Pharmacology · 2026-07 · 40 (4)

DOI: 10.1111/fcp.70102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, online erschienen am 27.06.2026. Verfasst von Şahhan Kılıç und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ministry of Health Çorlu State Hospital, Çorlu, Tekirdağ, Türkiye. Hauptthemen laut MEDLINE: Colchicine, Hyperbaric Oxygenation, Myocardial Reperfusion Injury, Cardiotonic Agents. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Lower extremity ischemia‐reperfusion injury (IRI) triggers systemic inflammation and oxidative stress, causing myocardial remote ischemia‐reperfusion injury (MIRI). Current treatments are limited.

Methods

Male Sprague‐Dawley rats ( n = 6 per group) were assigned to Sham, I/R, I/R + colchicine (C), I/R + HBOT, and I/R + HBOT + C. IRI was induced by 60‐min infrarenal aortic clamping and 120‐h reperfusion. Treatment Once daily colchicine (0.3 mg/kg) and HBOT (2.5 ATA, 100% O 2 ) twice daily were administered for 5 days post‐reperfusion. Cardiac damage, oxidative stress, inflammation, and NRF‐2/HO‐1 signaling were measured, and electrocardiography (ECG) was performed.

Results

I/R caused severe MIRI (Hs‐Troponin T: 568.54 pg/mL; heart OSI: 20.98; TNF‐α: 582.89 pg/mL). Both monotherapies reduced damage, but HBOT + C was superior: Hs‐Troponin T 342.07 pg/mL, OSI 2.26, TNF‐α 278.82 pg/mL, and IL‐6 12.25 pg/mL, with the upper end of the interquartile range for NRF‐2 (41.03) and HO‐1 (14.45) activation and restored redox balance (%DIS/NT: 26.31). No differences were observed between groups on the ECG.

Conclusions

Colchicine suppresses inflammation, relieving inhibition of antioxidant defenses, enabling HBOT to fully activate NRF‐2/HO‐1. This synergistic HBOT + C strategy effectively mitigates MIRI, offering a promising multimodal therapy for remote organ protection after major ischemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineHyperbaric OxygenationMyocardial Reperfusion InjuryCardiotonic AgentsReperfusion InjuryAnimalsMaleRats, Sprague-DawleyRatsOxidative StressDisease Models, AnimalNF-E2-Related Factor 2ElectrocardiographyInflammation

Stichwörter der Autor:innen

colchicineheart injurieshyperbaric oxygenationinflammationischemia‐reperfusion injuryoxidative stress

Substanzen

ColchicineCardiotonic AgentsNF-E2-Related Factor 2Nfe2l2 protein, rat

Autor:innen und Institutionen

  • Department of Cardiology, Ministry of Health Çorlu State Hospital, Çorlu, Tekirdağ, Türkiye.
  • Department of Cardiology, Health Sciences University Sultan 2. Abdülhamid Han Training and Research Hospital, Üsküdar, İstanbul, Türkiye.
  • Veterinary Clinic, Health Sciences University Hamidiye Experimental Animals Laboratory, İstanbul, Türkiye.
  • Department of Medical Biochemistry, Health Sciences University Hamidiye Faculty of Medicine, İstanbul, Türkiye.
  • Department of Underwater and Hyperbaric Medicine, Health Sciences University Sultan 2. Abdülhamid Han Training and Research Hospital, Üsküdar, İstanbul, Türkiye.
  • Department of Pathology, İstanbul University-Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.

ORCID-Profile: Şahhan Kılıç, Süha Asal, Mert Babaoğlu, Cumaali Demirtaş, Samet Yavuz, Eray Metin Güler, Hakan Beyaztaş, Yavuz Aslan, Cansu Türker Sarıçoban, Özge Bengisu Uysal, Mehmet Yıldırım, Mert İlker Hayıroğlu, Tufan Çınar

Zitieren

APA

Kılıç, Ş., Asal, S., Babaoğlu, M., Demirtaş, C., Yavuz, S., Güler, E. M., Beyaztaş, H., Aslan, Y., Türker Sarıçoban, C., Uysal, Ö. B., Yıldırım, M., Hayıroğlu, M. İ., & Çınar, T. (2026). Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia‐Reperfusion Injury. Fundamental & Clinical Pharmacology, 40(4). https://doi.org/10.1111/fcp.70102

Vancouver

Kılıç Ş, Asal S, Babaoğlu M, Demirtaş C, Yavuz S, Güler EM, et al. Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia‐Reperfusion Injury. Fundamental & Clinical Pharmacology. 2026;40(4). doi:10.1111/fcp.70102

BibTeX
@article{Kl2026,
  author = {Kılıç, Şahhan and Asal, Süha and Babaoğlu, Mert and Demirtaş, Cumaali and Yavuz, Samet and Güler, Eray Metin and Beyaztaş, Hakan and Aslan, Yavuz and Türker Sarıçoban, Cansu and Uysal, Özge Bengisu and Yıldırım, Mehmet and Hayıroğlu, Mert İlker and Çınar, Tufan},
  title = {Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia‐Reperfusion Injury},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2026},
  volume = {40},
  number = {4},
  doi = {10.1111/fcp.70102}
}
Kostenlos starten →